Announce Date | 01/30/2025 |
EPS Normalized Actual | $2.43 (Beat by $0.11) |
EPS GAAP Actual | $2.43 (Beat by $0.11) |
Revenue Actual | $1.28209B |
Revenue Surprise | Beat by $1282.09M |
Announce Date | 03/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.0638 |
EPS GAAP Estimate | $2.0638 |
Revenue Estimate | $1.21495112B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jun 2029 | 12.73 | 17.26 | 12.33767 | 13.26102 | 4 |
Jun 2028 | 10.31 | 21.32 | 9.87252 | 10.50599 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 2.43 | 0.25267 | 1.28209B | 9.3% | 40.3M |
FQ3 2024 (Sep 2024) | 2.119 | 2.119 | 1.22451B | 21.35% | 1224.51M |
FQ2 2024 (Jun 2024) | 1.989 | 1.989 | 1.2232B | 8.27% | 1223.2M |
FQ1 2024 (Mar 2024) | 0 | 0 | 1.19698B | 6.69% | 1196.98M |
FQ4 2023 (Dec 2023) | 0 | 0 | 1.1628B | 99.92% | 1162.8M |
FQ3 2023 (Sep 2023) | 1.49 | 1.49 | 0.963037B | 99.9% | 963.04M |
FQ2 2023 (Jun 2023) | 1.56 | 1.56 | 1.12206B | 99.92% | 1122.06M |
FQ1 2023 (Mar 2023) | 1.58 | 1.58 | 1.1169B | 100% | 1116.9M |
FQ4 Announce Date
03/30/2025 (Pre-Market)
Consensus EPS Estimates
2.0638
Consensus Revenue Estimates
1.21495112B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 2.6729 | -- | 2.61685 | 2.81959 | 3 |
FQ4 2026 (Dec 2026) | 2.6198 | -- | 2.56487 | 2.76357 | 3 |
FQ3 2026 (Jul 2026) | 2.45835 | -- | 2.40381 | 2.52237 | 1 |
FQ1 2026 (Mar 2026) | 2.2776 | -- | 2.2152 | 2.34864 | 5 |
FQ4 2025 (Oct 2025) | 2.16265 | -12.36 | 2.11467 | 2.21897 | 2 |
FQ3 2025 (Jul 2025) | 2.2625 | 6.34 | 2.21231 | 2.32142 | 2 |
FQ1 2025 (Mar 2025) | 2.0638 | -- | 2.00726 | 2.12817 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 1.42B | -- | 1.4B | 1.48B | 4 |
FQ4 2026 (Dec 2026) | 1.4B | -- | 1.37B | 1.46B | 5 |
FQ3 2026 (Jul 2026) | 1.39B | -- | 1.36B | 1.41B | 2 |
FQ1 2026 (Mar 2026) | 1.39B | -- | 1.36B | 1.42B | 7 |
FQ4 2025 (Oct 2025) | 1.28B | -0.41 | 1.26B | 1.3B | 1 |
FQ3 2025 (Jul 2025) | 1.3B | 5.52 | 1.27B | 1.32B | 1 |
FQ1 2025 (Mar 2025) | 1.21B | 1.48 | 1.19B | 1.24B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 2.17733 | 2.43 | 0.25267 | 10.4% |
FQ3 2024 (Sep 2024) | 2.119 | 2.119 | 100% | |
FQ2 2024 (Jun 2024) | 1.989 | 1.989 | 100% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 1.49 | 1.49 | 100% | |
FQ2 2023 (Jun 2023) | 1.56 | 1.56 | 100% | |
FQ1 2023 (Mar 2023) | 1.58 | 1.58 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $1.24B | $1.28B | $40.3M | 3.14% |
FQ3 2024 (Sep 2024) | $0B | $1.22B | $1224.51M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.22B | $1223.2M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.2B | $1196.98M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.16B | $1162.8M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.96B | $963.04M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.12B | $1122.06M | 100% |
FQ1 2023 (Mar 2023) | $0B | $1.12B | $1116.9M | 100% |